NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|341877879|gb|EGT33814|]
View 

hypothetical protein CAEBREN_15291 [Caenorhabditis brenneri]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
118-799 8.18e-130

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 401.36  E-value: 8.18e-130
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 118 VEPCDNFYQFACGGWINQSVNLK-YDSWNTLYETQrtshDQIVQAMHKI-NDGSYPLPTNAGERAAAKMYEQCMDTDTLE 195
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPAdKSSWGSFSELQ----DRNEEQLREIlEEAASSAADSSAEQKAKDFYKSCMDEEAIE 76
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 196 QTGLHLWERFVDELGGWmpelkngmleqeesfeieldedeKKRRRFEIEDIILSAFNYSVFPLFWAGVEVNYLDSKEHLI 275
Cdd:cd08662   77 KLGLKPLKPLLDKIGGL-----------------------PSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNIL 133
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 276 TIYEqlPILLAPEKYHYDKELTPEMIygkmegppvtRALQQVGEELAAVLGFDssDEKVRMMIANMIYLEYQI--TIAGS 353
Cdd:cd08662  134 YLGQ--PGLGLPDRDYYLDEENAEIR----------EAYKKYIAKLLELLGAD--EEEAEKLAEDVLAFETELakISLSS 199
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 354 TFYKEKKERYTVVTLRELQEIAPAINWHYFLSRLvGENLSHSEPIALKTgtqwIPILSAIVEKLKQTRsgVAVLKNYVKW 433
Cdd:cd08662  200 EELRDPEKTYNPLTLAELQKLAPSIDWKAYLKAL-GPPADDPDKVIVSQ----PEYLKKLDKLLASTP--LRTLKNYLIW 272
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 434 KTIMFHLAYASPKCRDGLLWMAVSLYSGAASQ-RKEFCVLRLSGIFPLSLPSI-LRKIDgidhTEKNVKAVQDVADRIQE 511
Cdd:cd08662  273 RLLDSLAPYLSKEFRDARFFYGKALSGQKEPEpRWKRCVELVNGALGEALGRLyVEKYF----SEEAKADVEEMVENIKE 348
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 512 KYEEMVKSSN-LfsDSETRQNVVDKVNNMTKFIGFPDAMRSDFEMEKEA--IRLHDSLFWSMVLGSSSVYKERLQRLRLP 588
Cdd:cd08662  349 AFKERLENLDwM--DEETKKKALEKLDAMKVKIGYPDKWRDYSALDIYYddLNVSDSYFENVLRLLRFETKRQLAKLGKP 426
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 589 VNPRDWVDTrPAISVPAHNYERNLIQIPFDSLRLPYADEHQLDFANYAGIGTIIGHEFTHAFDGQGKLHGPTGNLGSWWS 668
Cdd:cd08662  427 VDRTEWSMS-PQTVNAYYNPSLNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWT 505
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 669 QESSRRFKAREQCFIKQYAGLMDSHDMNA-AKEGLYENIADHVGLKVAYEAWKANGNQNSARMPGLEKYSQDQLFFLAYT 747
Cdd:cd08662  506 NEDRKEFEERAQCLVDQYSNYEVPPGLHVnGKLTLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSFA 585
                        650       660       670       680       690
                 ....*....|....*....|....*....|....*....|....*....|....*..
gi 341877879 748 QGWCALRSKSYKLQ-----PHMEERIRMLGSLQNSPEFASAWNCPTDSFMNPPDKCT 799
Cdd:cd08662  586 QVWCSKYRPEALRQllltdPHSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
118-799 8.18e-130

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 401.36  E-value: 8.18e-130
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 118 VEPCDNFYQFACGGWINQSVNLK-YDSWNTLYETQrtshDQIVQAMHKI-NDGSYPLPTNAGERAAAKMYEQCMDTDTLE 195
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPAdKSSWGSFSELQ----DRNEEQLREIlEEAASSAADSSAEQKAKDFYKSCMDEEAIE 76
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 196 QTGLHLWERFVDELGGWmpelkngmleqeesfeieldedeKKRRRFEIEDIILSAFNYSVFPLFWAGVEVNYLDSKEHLI 275
Cdd:cd08662   77 KLGLKPLKPLLDKIGGL-----------------------PSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNIL 133
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 276 TIYEqlPILLAPEKYHYDKELTPEMIygkmegppvtRALQQVGEELAAVLGFDssDEKVRMMIANMIYLEYQI--TIAGS 353
Cdd:cd08662  134 YLGQ--PGLGLPDRDYYLDEENAEIR----------EAYKKYIAKLLELLGAD--EEEAEKLAEDVLAFETELakISLSS 199
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 354 TFYKEKKERYTVVTLRELQEIAPAINWHYFLSRLvGENLSHSEPIALKTgtqwIPILSAIVEKLKQTRsgVAVLKNYVKW 433
Cdd:cd08662  200 EELRDPEKTYNPLTLAELQKLAPSIDWKAYLKAL-GPPADDPDKVIVSQ----PEYLKKLDKLLASTP--LRTLKNYLIW 272
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 434 KTIMFHLAYASPKCRDGLLWMAVSLYSGAASQ-RKEFCVLRLSGIFPLSLPSI-LRKIDgidhTEKNVKAVQDVADRIQE 511
Cdd:cd08662  273 RLLDSLAPYLSKEFRDARFFYGKALSGQKEPEpRWKRCVELVNGALGEALGRLyVEKYF----SEEAKADVEEMVENIKE 348
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 512 KYEEMVKSSN-LfsDSETRQNVVDKVNNMTKFIGFPDAMRSDFEMEKEA--IRLHDSLFWSMVLGSSSVYKERLQRLRLP 588
Cdd:cd08662  349 AFKERLENLDwM--DEETKKKALEKLDAMKVKIGYPDKWRDYSALDIYYddLNVSDSYFENVLRLLRFETKRQLAKLGKP 426
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 589 VNPRDWVDTrPAISVPAHNYERNLIQIPFDSLRLPYADEHQLDFANYAGIGTIIGHEFTHAFDGQGKLHGPTGNLGSWWS 668
Cdd:cd08662  427 VDRTEWSMS-PQTVNAYYNPSLNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWT 505
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 669 QESSRRFKAREQCFIKQYAGLMDSHDMNA-AKEGLYENIADHVGLKVAYEAWKANGNQNSARMPGLEKYSQDQLFFLAYT 747
Cdd:cd08662  506 NEDRKEFEERAQCLVDQYSNYEVPPGLHVnGKLTLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSFA 585
                        650       660       670       680       690
                 ....*....|....*....|....*....|....*....|....*....|....*..
gi 341877879 748 QGWCALRSKSYKLQ-----PHMEERIRMLGSLQNSPEFASAWNCPTDSFMNPPDKCT 799
Cdd:cd08662  586 QVWCSKYRPEALRQllltdPHSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
111-801 1.13e-57

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 209.24  E-value: 1.13e-57
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 111 LKRVDSSVEPCDNFYQFACGGWI-------NQSVnlkYDSWNTLYETQRtshdqivQAMHKINDG--SYPLPTNAGERAA 181
Cdd:COG3590   30 LANMDTSVRPGDDFYRYVNGGWLkttpipaDRSR---WGSFNELRERNE-------ARLRAILEEaaAAPAAAGSDEQKI 99
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 182 AKMYEQCMDTDTLEQTGLhlwerfvdelggwmpelkngmleqeESFEIELDEDEKKRRRFEIEDIILSAFNYSVFPLFWA 261
Cdd:COG3590  100 GDLYASFMDEAAIEALGL-------------------------APLKPDLARIDAIKDKADLAALLAALHRAGVGGLFGF 154
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 262 GVEVNYLDSKEHLITIYeQLPILLaPEKYHYDKElTPEMI-----YGKMegppVTRALqqvgeELAavlGFDSSDEKVRm 336
Cdd:COG3590  155 GVDADLKNSTRYIAYLG-QGGLGL-PDRDYYLKD-DEKSAeiraaYVAH----VAKML-----ELA---GYDEADAAAA- 218
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 337 miANMIY-LEYQItiAGSTFYKEK----KERYTVVTLRELQEIAPAINWHYFLSRLVGENLSH---SEPIALKTgtqwip 408
Cdd:COG3590  219 --AEAVLaLETAL--AKAHWSRVElrdpEKTYNPMTVAELAKLAPGFDWDAYLKALGLPAVDEvivGQPSFFKA------ 288
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 409 iLSAIVEKLKqtrsgVAVLKNYVKWKTIMFHLAYASPKCRDgllwMAVSLY----SGAASQ--RKEFCVLRLSGIFPLSL 482
Cdd:COG3590  289 -LDKLLASTP-----LEDWKAYLRWHLLDSAAPYLSKAFVD----ANFDFYgktlSGQKEQrpRWKRAVALVNGALGEAL 358
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 483 psilrkidGIDHTEKNVKA-----VQDVADRIQEKYEEMVKSSNLFSDsETRQNVVDKVNNMTKFIGFPDAMR--SDFEM 555
Cdd:COG3590  359 --------GQLYVERYFPPeakarMEELVANLRAAYRERIENLDWMSP-ETKAKALEKLAAFTPKIGYPDKWRdySGLEI 429
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 556 EKeairlhDSLFWSMVLGSSSVYKERLQRLRLPVNPRDWVDTRPaiSVPAH-NYERNLIQIP--------FDslrlPYAD 626
Cdd:COG3590  430 KR------DDLVGNVLRASAFEYQRELAKLGKPVDRTEWGMTPQ--TVNAYyNPTMNEIVFPaailqppfFD----PKAD 497
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 627 ehqlDFANYAGIGTIIGHEFTHAFDGQGKLHGPTGNLGSWWSQESSRRFKAREQCFIKQYAGL--MDSHDMNaakeG--- 701
Cdd:COG3590  498 ----DAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKKLVAQYDAYepLPGLHVN----Gklt 569
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 702 LYENIADHVGLKVAYEAWKANGNQNSArmPGLEKYSQDQLFFLAYTQGWCALRSKSYKLQ-----PHMEERIRMLGSLQN 776
Cdd:COG3590  570 LGENIADLGGLSIAYDAYKLSLKGKEA--PVIDGFTGDQRFFLGWAQVWRSKARDEALRQrlatdPHSPGEFRVNGPVRN 647
                        730       740
                 ....*....|....*....|....*..
gi 341877879 777 SPEFASAWNC-PTDSFMNPPDK-CTIW 801
Cdd:COG3590  648 LDAFYEAFDVkPGDKMYLAPEDrVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
120-546 3.35e-47

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 172.48  E-value: 3.35e-47
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879  120 PCDNFYQFACGGWI-NQSVNLKYDSWNTLYETQrtshDQIVQAMHKI-NDGSYPLPTNAGERAAAKMYEQCMDTDTLEQT 197
Cdd:pfam05649   1 PCDDFYQYACGGWLkNHPIPADKSSWGTFDELR----ERNEKQLREIlEEAAASESDPGAVEKAKDLYKSCMDTDAIEKL 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879  198 GLHLWERFVDELGGWMPelkngmleqeesfeieldedekKRRRFEIEDIILSAFNYSVFPLFWAGVEVNYLDSKEHLITI 277
Cdd:pfam05649  77 GLKPLKPLLDEIGGPLA----------------------NKDKFDLLETLAKLRRYGVDSLFGFGVGPDDKNSSRNILYL 134
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879  278 YEQLPILlaPEKYHYDKELTPEMiygkmegPPVTRALQQVGEELAAVLGFDSSDEKvrmMIANMIYLEYQitIAGSTFYK 357
Cdd:pfam05649 135 DQPGLGL--PDRDYYLKDRDEKS-------AEIREAYKAYIAKLLTLLGASEEAAA---LAEEVLAFETK--LAKASLSR 200
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879  358 EKKE----RYTVVTLRELQEIAPAINWHYFLSRLVGENlSHSEPIALkTGTQWIPILSAIvekLKQTRsgVAVLKNYVKW 433
Cdd:pfam05649 201 EERRdpekTYNPMTLAELQKLAPGIDWKAYLNAAGLPD-VPSDEVIV-SQPEYLKALSKL---LAETP--LRTLKNYLIW 273
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879  434 KTIMFHLAYASPKCRDgllwMAVSLY---SGAASQ-RKEFCVLRLSGIFPLSLPSILRKidgiDH-TEKNVKAVQDVADR 508
Cdd:pfam05649 274 RLVRSLAPYLSDEFRD----ANFEFYgtlSGTKQRpRWKRCVSLVNGLLGEALGRLYVK----KYfPEEAKARVEELVEN 345
                         410       420       430
                  ....*....|....*....|....*....|....*...
gi 341877879  509 IQEKYEEMVKSSNLFSDsETRQNVVDKVNNMTKFIGFP 546
Cdd:pfam05649 346 IKEAFRERLDELDWMDE-ETKKKALEKLDAMTVKIGYP 382
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
118-799 8.18e-130

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 401.36  E-value: 8.18e-130
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 118 VEPCDNFYQFACGGWINQSVNLK-YDSWNTLYETQrtshDQIVQAMHKI-NDGSYPLPTNAGERAAAKMYEQCMDTDTLE 195
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPAdKSSWGSFSELQ----DRNEEQLREIlEEAASSAADSSAEQKAKDFYKSCMDEEAIE 76
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 196 QTGLHLWERFVDELGGWmpelkngmleqeesfeieldedeKKRRRFEIEDIILSAFNYSVFPLFWAGVEVNYLDSKEHLI 275
Cdd:cd08662   77 KLGLKPLKPLLDKIGGL-----------------------PSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNIL 133
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 276 TIYEqlPILLAPEKYHYDKELTPEMIygkmegppvtRALQQVGEELAAVLGFDssDEKVRMMIANMIYLEYQI--TIAGS 353
Cdd:cd08662  134 YLGQ--PGLGLPDRDYYLDEENAEIR----------EAYKKYIAKLLELLGAD--EEEAEKLAEDVLAFETELakISLSS 199
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 354 TFYKEKKERYTVVTLRELQEIAPAINWHYFLSRLvGENLSHSEPIALKTgtqwIPILSAIVEKLKQTRsgVAVLKNYVKW 433
Cdd:cd08662  200 EELRDPEKTYNPLTLAELQKLAPSIDWKAYLKAL-GPPADDPDKVIVSQ----PEYLKKLDKLLASTP--LRTLKNYLIW 272
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 434 KTIMFHLAYASPKCRDGLLWMAVSLYSGAASQ-RKEFCVLRLSGIFPLSLPSI-LRKIDgidhTEKNVKAVQDVADRIQE 511
Cdd:cd08662  273 RLLDSLAPYLSKEFRDARFFYGKALSGQKEPEpRWKRCVELVNGALGEALGRLyVEKYF----SEEAKADVEEMVENIKE 348
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 512 KYEEMVKSSN-LfsDSETRQNVVDKVNNMTKFIGFPDAMRSDFEMEKEA--IRLHDSLFWSMVLGSSSVYKERLQRLRLP 588
Cdd:cd08662  349 AFKERLENLDwM--DEETKKKALEKLDAMKVKIGYPDKWRDYSALDIYYddLNVSDSYFENVLRLLRFETKRQLAKLGKP 426
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 589 VNPRDWVDTrPAISVPAHNYERNLIQIPFDSLRLPYADEHQLDFANYAGIGTIIGHEFTHAFDGQGKLHGPTGNLGSWWS 668
Cdd:cd08662  427 VDRTEWSMS-PQTVNAYYNPSLNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWT 505
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 669 QESSRRFKAREQCFIKQYAGLMDSHDMNA-AKEGLYENIADHVGLKVAYEAWKANGNQNSARMPGLEKYSQDQLFFLAYT 747
Cdd:cd08662  506 NEDRKEFEERAQCLVDQYSNYEVPPGLHVnGKLTLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSFA 585
                        650       660       670       680       690
                 ....*....|....*....|....*....|....*....|....*....|....*..
gi 341877879 748 QGWCALRSKSYKLQ-----PHMEERIRMLGSLQNSPEFASAWNCPTDSFMNPPDKCT 799
Cdd:cd08662  586 QVWCSKYRPEALRQllltdPHSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
111-801 1.13e-57

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 209.24  E-value: 1.13e-57
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 111 LKRVDSSVEPCDNFYQFACGGWI-------NQSVnlkYDSWNTLYETQRtshdqivQAMHKINDG--SYPLPTNAGERAA 181
Cdd:COG3590   30 LANMDTSVRPGDDFYRYVNGGWLkttpipaDRSR---WGSFNELRERNE-------ARLRAILEEaaAAPAAAGSDEQKI 99
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 182 AKMYEQCMDTDTLEQTGLhlwerfvdelggwmpelkngmleqeESFEIELDEDEKKRRRFEIEDIILSAFNYSVFPLFWA 261
Cdd:COG3590  100 GDLYASFMDEAAIEALGL-------------------------APLKPDLARIDAIKDKADLAALLAALHRAGVGGLFGF 154
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 262 GVEVNYLDSKEHLITIYeQLPILLaPEKYHYDKElTPEMI-----YGKMegppVTRALqqvgeELAavlGFDSSDEKVRm 336
Cdd:COG3590  155 GVDADLKNSTRYIAYLG-QGGLGL-PDRDYYLKD-DEKSAeiraaYVAH----VAKML-----ELA---GYDEADAAAA- 218
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 337 miANMIY-LEYQItiAGSTFYKEK----KERYTVVTLRELQEIAPAINWHYFLSRLVGENLSH---SEPIALKTgtqwip 408
Cdd:COG3590  219 --AEAVLaLETAL--AKAHWSRVElrdpEKTYNPMTVAELAKLAPGFDWDAYLKALGLPAVDEvivGQPSFFKA------ 288
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 409 iLSAIVEKLKqtrsgVAVLKNYVKWKTIMFHLAYASPKCRDgllwMAVSLY----SGAASQ--RKEFCVLRLSGIFPLSL 482
Cdd:COG3590  289 -LDKLLASTP-----LEDWKAYLRWHLLDSAAPYLSKAFVD----ANFDFYgktlSGQKEQrpRWKRAVALVNGALGEAL 358
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 483 psilrkidGIDHTEKNVKA-----VQDVADRIQEKYEEMVKSSNLFSDsETRQNVVDKVNNMTKFIGFPDAMR--SDFEM 555
Cdd:COG3590  359 --------GQLYVERYFPPeakarMEELVANLRAAYRERIENLDWMSP-ETKAKALEKLAAFTPKIGYPDKWRdySGLEI 429
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 556 EKeairlhDSLFWSMVLGSSSVYKERLQRLRLPVNPRDWVDTRPaiSVPAH-NYERNLIQIP--------FDslrlPYAD 626
Cdd:COG3590  430 KR------DDLVGNVLRASAFEYQRELAKLGKPVDRTEWGMTPQ--TVNAYyNPTMNEIVFPaailqppfFD----PKAD 497
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 627 ehqlDFANYAGIGTIIGHEFTHAFDGQGKLHGPTGNLGSWWSQESSRRFKAREQCFIKQYAGL--MDSHDMNaakeG--- 701
Cdd:COG3590  498 ----DAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKKLVAQYDAYepLPGLHVN----Gklt 569
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879 702 LYENIADHVGLKVAYEAWKANGNQNSArmPGLEKYSQDQLFFLAYTQGWCALRSKSYKLQ-----PHMEERIRMLGSLQN 776
Cdd:COG3590  570 LGENIADLGGLSIAYDAYKLSLKGKEA--PVIDGFTGDQRFFLGWAQVWRSKARDEALRQrlatdPHSPGEFRVNGPVRN 647
                        730       740
                 ....*....|....*....|....*..
gi 341877879 777 SPEFASAWNC-PTDSFMNPPDK-CTIW 801
Cdd:COG3590  648 LDAFYEAFDVkPGDKMYLAPEDrVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
120-546 3.35e-47

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 172.48  E-value: 3.35e-47
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879  120 PCDNFYQFACGGWI-NQSVNLKYDSWNTLYETQrtshDQIVQAMHKI-NDGSYPLPTNAGERAAAKMYEQCMDTDTLEQT 197
Cdd:pfam05649   1 PCDDFYQYACGGWLkNHPIPADKSSWGTFDELR----ERNEKQLREIlEEAAASESDPGAVEKAKDLYKSCMDTDAIEKL 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879  198 GLHLWERFVDELGGWMPelkngmleqeesfeieldedekKRRRFEIEDIILSAFNYSVFPLFWAGVEVNYLDSKEHLITI 277
Cdd:pfam05649  77 GLKPLKPLLDEIGGPLA----------------------NKDKFDLLETLAKLRRYGVDSLFGFGVGPDDKNSSRNILYL 134
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879  278 YEQLPILlaPEKYHYDKELTPEMiygkmegPPVTRALQQVGEELAAVLGFDSSDEKvrmMIANMIYLEYQitIAGSTFYK 357
Cdd:pfam05649 135 DQPGLGL--PDRDYYLKDRDEKS-------AEIREAYKAYIAKLLTLLGASEEAAA---LAEEVLAFETK--LAKASLSR 200
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879  358 EKKE----RYTVVTLRELQEIAPAINWHYFLSRLVGENlSHSEPIALkTGTQWIPILSAIvekLKQTRsgVAVLKNYVKW 433
Cdd:pfam05649 201 EERRdpekTYNPMTLAELQKLAPGIDWKAYLNAAGLPD-VPSDEVIV-SQPEYLKALSKL---LAETP--LRTLKNYLIW 273
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879  434 KTIMFHLAYASPKCRDgllwMAVSLY---SGAASQ-RKEFCVLRLSGIFPLSLPSILRKidgiDH-TEKNVKAVQDVADR 508
Cdd:pfam05649 274 RLVRSLAPYLSDEFRD----ANFEFYgtlSGTKQRpRWKRCVSLVNGLLGEALGRLYVK----KYfPEEAKARVEELVEN 345
                         410       420       430
                  ....*....|....*....|....*....|....*...
gi 341877879  509 IQEKYEEMVKSSNLFSDsETRQNVVDKVNNMTKFIGFP 546
Cdd:pfam05649 346 IKEAFRERLDELDWMDE-ETKKKALEKLDAMTVKIGYP 382
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
606-798 3.49e-46

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 163.74  E-value: 3.49e-46
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879  606 HNYERNLIQIPFDSLRLPYADEHQLDFANYAGIGTIIGHEFTHAFDGQGKLHGPTGNLGSWWSQESSRRFKAREQCFIKQ 685
Cdd:pfam01431   4 YQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQCLIEQ 83
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 341877879  686 YAGLMDSHDMNAAKEG--LYENIADHVGLKVAYEAWKANGNQNSARMPGLEKYSQDQLFFLAYTQGWCALRSKSYKLQ-- 761
Cdd:pfam01431  84 YSEYTPPDGTKCANGTltLGENIADLGGLTIALRAYKKLLSANETVLPGFENLTPDQLFFRGAAQIWCMKQSPAEVLRql 163
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|
gi 341877879  762 ---PHMEERIRMLGSLQNSPEFASAWNCPTDSFMNPPDKC 798
Cdd:pfam01431 164 lvdPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRC 203
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH